Medical Care
Global Coronavirus Infection Market Research Report 2025
- Jun 28, 25
- ID: 346897
- Pages: 72
- Figures: 75
- Views: 13
The global market for Coronavirus Infection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Coronavirus Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronavirus Infection.
The Coronavirus Infection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Coronavirus Infection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coronavirus Infection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca Plc
Hemispherx Biopharma Inc.
Humabs BioMed SA
Kineta Inc.
NanoViricides Inc.
Novavax Inc.
Organic Vaccines
Phelix Therapeutics LLC
Regeneron Pharmaceuticals Inc.
Segment by Type
FBR-001
INO-4500
Interferon α-n3
Interferon β-1ａ
LCA-60
Infect Small Molecules
MERS-CoV Vaccine
Monclonalantiboby
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Coronavirus Infection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Coronavirus Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronavirus Infection.
The Coronavirus Infection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Coronavirus Infection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coronavirus Infection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca Plc
Hemispherx Biopharma Inc.
Humabs BioMed SA
Kineta Inc.
NanoViricides Inc.
Novavax Inc.
Organic Vaccines
Phelix Therapeutics LLC
Regeneron Pharmaceuticals Inc.
Segment by Type
FBR-001
INO-4500
Interferon α-n3
Interferon β-1ａ
LCA-60
Infect Small Molecules
MERS-CoV Vaccine
Monclonalantiboby
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Coronavirus Infection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Coronavirus Infection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 FBR-001
1.2.3 INO-4500
1.2.4 Interferon α-n3
1.2.5 Interferon β-1ａ
1.2.6 LCA-60
1.2.7 Infect Small Molecules
1.2.8 MERS-CoV Vaccine
1.2.9 Monclonalantiboby
1.3 Market by Application
1.3.1 Global Coronavirus Infection Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Coronavirus Infection Market Perspective (2020-2031)
2.2 Global Coronavirus Infection Growth Trends by Region
2.2.1 Global Coronavirus Infection Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Coronavirus Infection Historic Market Size by Region (2020-2025)
2.2.3 Coronavirus Infection Forecasted Market Size by Region (2026-2031)
2.3 Coronavirus Infection Market Dynamics
2.3.1 Coronavirus Infection Industry Trends
2.3.2 Coronavirus Infection Market Drivers
2.3.3 Coronavirus Infection Market Challenges
2.3.4 Coronavirus Infection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Coronavirus Infection Players by Revenue
3.1.1 Global Top Coronavirus Infection Players by Revenue (2020-2025)
3.1.2 Global Coronavirus Infection Revenue Market Share by Players (2020-2025)
3.2 Global Coronavirus Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Coronavirus Infection Revenue
3.4 Global Coronavirus Infection Market Concentration Ratio
3.4.1 Global Coronavirus Infection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Coronavirus Infection Revenue in 2024
3.5 Global Key Players of Coronavirus Infection Head office and Area Served
3.6 Global Key Players of Coronavirus Infection, Product and Application
3.7 Global Key Players of Coronavirus Infection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Coronavirus Infection Breakdown Data by Type
4.1 Global Coronavirus Infection Historic Market Size by Type (2020-2025)
4.2 Global Coronavirus Infection Forecasted Market Size by Type (2026-2031)
5 Coronavirus Infection Breakdown Data by Application
5.1 Global Coronavirus Infection Historic Market Size by Application (2020-2025)
5.2 Global Coronavirus Infection Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Coronavirus Infection Market Size (2020-2031)
6.2 North America Coronavirus Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Coronavirus Infection Market Size by Country (2020-2025)
6.4 North America Coronavirus Infection Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Coronavirus Infection Market Size (2020-2031)
7.2 Europe Coronavirus Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Coronavirus Infection Market Size by Country (2020-2025)
7.4 Europe Coronavirus Infection Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Coronavirus Infection Market Size (2020-2031)
8.2 Asia-Pacific Coronavirus Infection Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Coronavirus Infection Market Size by Region (2020-2025)
8.4 Asia-Pacific Coronavirus Infection Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Coronavirus Infection Market Size (2020-2031)
9.2 Latin America Coronavirus Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Coronavirus Infection Market Size by Country (2020-2025)
9.4 Latin America Coronavirus Infection Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Coronavirus Infection Market Size (2020-2031)
10.2 Middle East & Africa Coronavirus Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Coronavirus Infection Market Size by Country (2020-2025)
10.4 Middle East & Africa Coronavirus Infection Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc Coronavirus Infection Introduction
11.1.4 AstraZeneca Plc Revenue in Coronavirus Infection Business (2020-2025)
11.1.5 AstraZeneca Plc Recent Development
11.2 Hemispherx Biopharma Inc.
11.2.1 Hemispherx Biopharma Inc. Company Details
11.2.2 Hemispherx Biopharma Inc. Business Overview
11.2.3 Hemispherx Biopharma Inc. Coronavirus Infection Introduction
11.2.4 Hemispherx Biopharma Inc. Revenue in Coronavirus Infection Business (2020-2025)
11.2.5 Hemispherx Biopharma Inc. Recent Development
11.3 Humabs BioMed SA
11.3.1 Humabs BioMed SA Company Details
11.3.2 Humabs BioMed SA Business Overview
11.3.3 Humabs BioMed SA Coronavirus Infection Introduction
11.3.4 Humabs BioMed SA Revenue in Coronavirus Infection Business (2020-2025)
11.3.5 Humabs BioMed SA Recent Development
11.4 Kineta Inc.
11.4.1 Kineta Inc. Company Details
11.4.2 Kineta Inc. Business Overview
11.4.3 Kineta Inc. Coronavirus Infection Introduction
11.4.4 Kineta Inc. Revenue in Coronavirus Infection Business (2020-2025)
11.4.5 Kineta Inc. Recent Development
11.5 NanoViricides Inc.
11.5.1 NanoViricides Inc. Company Details
11.5.2 NanoViricides Inc. Business Overview
11.5.3 NanoViricides Inc. Coronavirus Infection Introduction
11.5.4 NanoViricides Inc. Revenue in Coronavirus Infection Business (2020-2025)
11.5.5 NanoViricides Inc. Recent Development
11.6 Novavax Inc.
11.6.1 Novavax Inc. Company Details
11.6.2 Novavax Inc. Business Overview
11.6.3 Novavax Inc. Coronavirus Infection Introduction
11.6.4 Novavax Inc. Revenue in Coronavirus Infection Business (2020-2025)
11.6.5 Novavax Inc. Recent Development
11.7 Organic Vaccines
11.7.1 Organic Vaccines Company Details
11.7.2 Organic Vaccines Business Overview
11.7.3 Organic Vaccines Coronavirus Infection Introduction
11.7.4 Organic Vaccines Revenue in Coronavirus Infection Business (2020-2025)
11.7.5 Organic Vaccines Recent Development
11.8 Phelix Therapeutics LLC
11.8.1 Phelix Therapeutics LLC Company Details
11.8.2 Phelix Therapeutics LLC Business Overview
11.8.3 Phelix Therapeutics LLC Coronavirus Infection Introduction
11.8.4 Phelix Therapeutics LLC Revenue in Coronavirus Infection Business (2020-2025)
11.8.5 Phelix Therapeutics LLC Recent Development
11.9 Regeneron Pharmaceuticals Inc.
11.9.1 Regeneron Pharmaceuticals Inc. Company Details
11.9.2 Regeneron Pharmaceuticals Inc. Business Overview
11.9.3 Regeneron Pharmaceuticals Inc. Coronavirus Infection Introduction
11.9.4 Regeneron Pharmaceuticals Inc. Revenue in Coronavirus Infection Business (2020-2025)
11.9.5 Regeneron Pharmaceuticals Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Coronavirus Infection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 FBR-001
1.2.3 INO-4500
1.2.4 Interferon α-n3
1.2.5 Interferon β-1ａ
1.2.6 LCA-60
1.2.7 Infect Small Molecules
1.2.8 MERS-CoV Vaccine
1.2.9 Monclonalantiboby
1.3 Market by Application
1.3.1 Global Coronavirus Infection Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Coronavirus Infection Market Perspective (2020-2031)
2.2 Global Coronavirus Infection Growth Trends by Region
2.2.1 Global Coronavirus Infection Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Coronavirus Infection Historic Market Size by Region (2020-2025)
2.2.3 Coronavirus Infection Forecasted Market Size by Region (2026-2031)
2.3 Coronavirus Infection Market Dynamics
2.3.1 Coronavirus Infection Industry Trends
2.3.2 Coronavirus Infection Market Drivers
2.3.3 Coronavirus Infection Market Challenges
2.3.4 Coronavirus Infection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Coronavirus Infection Players by Revenue
3.1.1 Global Top Coronavirus Infection Players by Revenue (2020-2025)
3.1.2 Global Coronavirus Infection Revenue Market Share by Players (2020-2025)
3.2 Global Coronavirus Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Coronavirus Infection Revenue
3.4 Global Coronavirus Infection Market Concentration Ratio
3.4.1 Global Coronavirus Infection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Coronavirus Infection Revenue in 2024
3.5 Global Key Players of Coronavirus Infection Head office and Area Served
3.6 Global Key Players of Coronavirus Infection, Product and Application
3.7 Global Key Players of Coronavirus Infection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Coronavirus Infection Breakdown Data by Type
4.1 Global Coronavirus Infection Historic Market Size by Type (2020-2025)
4.2 Global Coronavirus Infection Forecasted Market Size by Type (2026-2031)
5 Coronavirus Infection Breakdown Data by Application
5.1 Global Coronavirus Infection Historic Market Size by Application (2020-2025)
5.2 Global Coronavirus Infection Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Coronavirus Infection Market Size (2020-2031)
6.2 North America Coronavirus Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Coronavirus Infection Market Size by Country (2020-2025)
6.4 North America Coronavirus Infection Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Coronavirus Infection Market Size (2020-2031)
7.2 Europe Coronavirus Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Coronavirus Infection Market Size by Country (2020-2025)
7.4 Europe Coronavirus Infection Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Coronavirus Infection Market Size (2020-2031)
8.2 Asia-Pacific Coronavirus Infection Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Coronavirus Infection Market Size by Region (2020-2025)
8.4 Asia-Pacific Coronavirus Infection Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Coronavirus Infection Market Size (2020-2031)
9.2 Latin America Coronavirus Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Coronavirus Infection Market Size by Country (2020-2025)
9.4 Latin America Coronavirus Infection Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Coronavirus Infection Market Size (2020-2031)
10.2 Middle East & Africa Coronavirus Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Coronavirus Infection Market Size by Country (2020-2025)
10.4 Middle East & Africa Coronavirus Infection Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc Coronavirus Infection Introduction
11.1.4 AstraZeneca Plc Revenue in Coronavirus Infection Business (2020-2025)
11.1.5 AstraZeneca Plc Recent Development
11.2 Hemispherx Biopharma Inc.
11.2.1 Hemispherx Biopharma Inc. Company Details
11.2.2 Hemispherx Biopharma Inc. Business Overview
11.2.3 Hemispherx Biopharma Inc. Coronavirus Infection Introduction
11.2.4 Hemispherx Biopharma Inc. Revenue in Coronavirus Infection Business (2020-2025)
11.2.5 Hemispherx Biopharma Inc. Recent Development
11.3 Humabs BioMed SA
11.3.1 Humabs BioMed SA Company Details
11.3.2 Humabs BioMed SA Business Overview
11.3.3 Humabs BioMed SA Coronavirus Infection Introduction
11.3.4 Humabs BioMed SA Revenue in Coronavirus Infection Business (2020-2025)
11.3.5 Humabs BioMed SA Recent Development
11.4 Kineta Inc.
11.4.1 Kineta Inc. Company Details
11.4.2 Kineta Inc. Business Overview
11.4.3 Kineta Inc. Coronavirus Infection Introduction
11.4.4 Kineta Inc. Revenue in Coronavirus Infection Business (2020-2025)
11.4.5 Kineta Inc. Recent Development
11.5 NanoViricides Inc.
11.5.1 NanoViricides Inc. Company Details
11.5.2 NanoViricides Inc. Business Overview
11.5.3 NanoViricides Inc. Coronavirus Infection Introduction
11.5.4 NanoViricides Inc. Revenue in Coronavirus Infection Business (2020-2025)
11.5.5 NanoViricides Inc. Recent Development
11.6 Novavax Inc.
11.6.1 Novavax Inc. Company Details
11.6.2 Novavax Inc. Business Overview
11.6.3 Novavax Inc. Coronavirus Infection Introduction
11.6.4 Novavax Inc. Revenue in Coronavirus Infection Business (2020-2025)
11.6.5 Novavax Inc. Recent Development
11.7 Organic Vaccines
11.7.1 Organic Vaccines Company Details
11.7.2 Organic Vaccines Business Overview
11.7.3 Organic Vaccines Coronavirus Infection Introduction
11.7.4 Organic Vaccines Revenue in Coronavirus Infection Business (2020-2025)
11.7.5 Organic Vaccines Recent Development
11.8 Phelix Therapeutics LLC
11.8.1 Phelix Therapeutics LLC Company Details
11.8.2 Phelix Therapeutics LLC Business Overview
11.8.3 Phelix Therapeutics LLC Coronavirus Infection Introduction
11.8.4 Phelix Therapeutics LLC Revenue in Coronavirus Infection Business (2020-2025)
11.8.5 Phelix Therapeutics LLC Recent Development
11.9 Regeneron Pharmaceuticals Inc.
11.9.1 Regeneron Pharmaceuticals Inc. Company Details
11.9.2 Regeneron Pharmaceuticals Inc. Business Overview
11.9.3 Regeneron Pharmaceuticals Inc. Coronavirus Infection Introduction
11.9.4 Regeneron Pharmaceuticals Inc. Revenue in Coronavirus Infection Business (2020-2025)
11.9.5 Regeneron Pharmaceuticals Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Coronavirus Infection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of FBR-001
Table 3. Key Players of INO-4500
Table 4. Key Players of Interferon α-n3
Table 5. Key Players of Interferon β-1ａ
Table 6. Key Players of LCA-60
Table 7. Key Players of Infect Small Molecules
Table 8. Key Players of MERS-CoV Vaccine
Table 9. Global Coronavirus Infection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Coronavirus Infection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Coronavirus Infection Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Coronavirus Infection Market Share by Region (2020-2025)
Table 13. Global Coronavirus Infection Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Coronavirus Infection Market Share by Region (2026-2031)
Table 15. Coronavirus Infection Market Trends
Table 16. Coronavirus Infection Market Drivers
Table 17. Coronavirus Infection Market Challenges
Table 18. Coronavirus Infection Market Restraints
Table 19. Global Coronavirus Infection Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Coronavirus Infection Market Share by Players (2020-2025)
Table 21. Global Top Coronavirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Infection as of 2024)
Table 22. Ranking of Global Top Coronavirus Infection Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Coronavirus Infection Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Coronavirus Infection, Headquarters and Area Served
Table 25. Global Key Players of Coronavirus Infection, Product and Application
Table 26. Global Key Players of Coronavirus Infection, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Coronavirus Infection Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Coronavirus Infection Revenue Market Share by Type (2020-2025)
Table 30. Global Coronavirus Infection Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Coronavirus Infection Revenue Market Share by Type (2026-2031)
Table 32. Global Coronavirus Infection Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Coronavirus Infection Revenue Market Share by Application (2020-2025)
Table 34. Global Coronavirus Infection Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Coronavirus Infection Revenue Market Share by Application (2026-2031)
Table 36. North America Coronavirus Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Coronavirus Infection Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Coronavirus Infection Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Coronavirus Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Coronavirus Infection Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Coronavirus Infection Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Coronavirus Infection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Coronavirus Infection Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Coronavirus Infection Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Coronavirus Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Coronavirus Infection Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Coronavirus Infection Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Coronavirus Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Coronavirus Infection Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Coronavirus Infection Market Size by Country (2026-2031) & (US$ Million)
Table 51. AstraZeneca Plc Company Details
Table 52. AstraZeneca Plc Business Overview
Table 53. AstraZeneca Plc Coronavirus Infection Product
Table 54. AstraZeneca Plc Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 55. AstraZeneca Plc Recent Development
Table 56. Hemispherx Biopharma Inc. Company Details
Table 57. Hemispherx Biopharma Inc. Business Overview
Table 58. Hemispherx Biopharma Inc. Coronavirus Infection Product
Table 59. Hemispherx Biopharma Inc. Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 60. Hemispherx Biopharma Inc. Recent Development
Table 61. Humabs BioMed SA Company Details
Table 62. Humabs BioMed SA Business Overview
Table 63. Humabs BioMed SA Coronavirus Infection Product
Table 64. Humabs BioMed SA Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 65. Humabs BioMed SA Recent Development
Table 66. Kineta Inc. Company Details
Table 67. Kineta Inc. Business Overview
Table 68. Kineta Inc. Coronavirus Infection Product
Table 69. Kineta Inc. Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 70. Kineta Inc. Recent Development
Table 71. NanoViricides Inc. Company Details
Table 72. NanoViricides Inc. Business Overview
Table 73. NanoViricides Inc. Coronavirus Infection Product
Table 74. NanoViricides Inc. Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 75. NanoViricides Inc. Recent Development
Table 76. Novavax Inc. Company Details
Table 77. Novavax Inc. Business Overview
Table 78. Novavax Inc. Coronavirus Infection Product
Table 79. Novavax Inc. Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 80. Novavax Inc. Recent Development
Table 81. Organic Vaccines Company Details
Table 82. Organic Vaccines Business Overview
Table 83. Organic Vaccines Coronavirus Infection Product
Table 84. Organic Vaccines Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 85. Organic Vaccines Recent Development
Table 86. Phelix Therapeutics LLC Company Details
Table 87. Phelix Therapeutics LLC Business Overview
Table 88. Phelix Therapeutics LLC Coronavirus Infection Product
Table 89. Phelix Therapeutics LLC Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 90. Phelix Therapeutics LLC Recent Development
Table 91. Regeneron Pharmaceuticals Inc. Company Details
Table 92. Regeneron Pharmaceuticals Inc. Business Overview
Table 93. Regeneron Pharmaceuticals Inc. Coronavirus Infection Product
Table 94. Regeneron Pharmaceuticals Inc. Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 95. Regeneron Pharmaceuticals Inc. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Coronavirus Infection Picture
Figure 2. Global Coronavirus Infection Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Coronavirus Infection Market Share by Type: 2024 VS 2031
Figure 4. FBR-001 Features
Figure 5. INO-4500 Features
Figure 6. Interferon α-n3 Features
Figure 7. Interferon β-1ａ Features
Figure 8. LCA-60 Features
Figure 9. Infect Small Molecules Features
Figure 10. MERS-CoV Vaccine Features
Figure 11. Monclonalantiboby Features
Figure 12. Global Coronavirus Infection Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Coronavirus Infection Market Share by Application: 2024 VS 2031
Figure 14. Hospital Case Studies
Figure 15. Clinic Case Studies
Figure 16. Other Case Studies
Figure 17. Coronavirus Infection Report Years Considered
Figure 18. Global Coronavirus Infection Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Coronavirus Infection Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Coronavirus Infection Market Share by Region: 2024 VS 2031
Figure 21. Global Coronavirus Infection Market Share by Players in 2024
Figure 22. Global Top Coronavirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Infection as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Coronavirus Infection Revenue in 2024
Figure 24. North America Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Coronavirus Infection Market Share by Country (2020-2031)
Figure 26. United States Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Coronavirus Infection Market Share by Country (2020-2031)
Figure 30. Germany Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Coronavirus Infection Market Share by Region (2020-2031)
Figure 38. China Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Coronavirus Infection Market Share by Country (2020-2031)
Figure 46. Mexico Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Coronavirus Infection Market Share by Country (2020-2031)
Figure 50. Turkey Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. AstraZeneca Plc Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 54. Hemispherx Biopharma Inc. Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 55. Humabs BioMed SA Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 56. Kineta Inc. Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 57. NanoViricides Inc. Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 58. Novavax Inc. Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 59. Organic Vaccines Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 60. Phelix Therapeutics LLC Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 61. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Coronavirus Infection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of FBR-001
Table 3. Key Players of INO-4500
Table 4. Key Players of Interferon α-n3
Table 5. Key Players of Interferon β-1ａ
Table 6. Key Players of LCA-60
Table 7. Key Players of Infect Small Molecules
Table 8. Key Players of MERS-CoV Vaccine
Table 9. Global Coronavirus Infection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Coronavirus Infection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Coronavirus Infection Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Coronavirus Infection Market Share by Region (2020-2025)
Table 13. Global Coronavirus Infection Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Coronavirus Infection Market Share by Region (2026-2031)
Table 15. Coronavirus Infection Market Trends
Table 16. Coronavirus Infection Market Drivers
Table 17. Coronavirus Infection Market Challenges
Table 18. Coronavirus Infection Market Restraints
Table 19. Global Coronavirus Infection Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Coronavirus Infection Market Share by Players (2020-2025)
Table 21. Global Top Coronavirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Infection as of 2024)
Table 22. Ranking of Global Top Coronavirus Infection Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Coronavirus Infection Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Coronavirus Infection, Headquarters and Area Served
Table 25. Global Key Players of Coronavirus Infection, Product and Application
Table 26. Global Key Players of Coronavirus Infection, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Coronavirus Infection Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Coronavirus Infection Revenue Market Share by Type (2020-2025)
Table 30. Global Coronavirus Infection Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Coronavirus Infection Revenue Market Share by Type (2026-2031)
Table 32. Global Coronavirus Infection Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Coronavirus Infection Revenue Market Share by Application (2020-2025)
Table 34. Global Coronavirus Infection Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Coronavirus Infection Revenue Market Share by Application (2026-2031)
Table 36. North America Coronavirus Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Coronavirus Infection Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Coronavirus Infection Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Coronavirus Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Coronavirus Infection Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Coronavirus Infection Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Coronavirus Infection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Coronavirus Infection Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Coronavirus Infection Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Coronavirus Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Coronavirus Infection Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Coronavirus Infection Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Coronavirus Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Coronavirus Infection Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Coronavirus Infection Market Size by Country (2026-2031) & (US$ Million)
Table 51. AstraZeneca Plc Company Details
Table 52. AstraZeneca Plc Business Overview
Table 53. AstraZeneca Plc Coronavirus Infection Product
Table 54. AstraZeneca Plc Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 55. AstraZeneca Plc Recent Development
Table 56. Hemispherx Biopharma Inc. Company Details
Table 57. Hemispherx Biopharma Inc. Business Overview
Table 58. Hemispherx Biopharma Inc. Coronavirus Infection Product
Table 59. Hemispherx Biopharma Inc. Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 60. Hemispherx Biopharma Inc. Recent Development
Table 61. Humabs BioMed SA Company Details
Table 62. Humabs BioMed SA Business Overview
Table 63. Humabs BioMed SA Coronavirus Infection Product
Table 64. Humabs BioMed SA Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 65. Humabs BioMed SA Recent Development
Table 66. Kineta Inc. Company Details
Table 67. Kineta Inc. Business Overview
Table 68. Kineta Inc. Coronavirus Infection Product
Table 69. Kineta Inc. Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 70. Kineta Inc. Recent Development
Table 71. NanoViricides Inc. Company Details
Table 72. NanoViricides Inc. Business Overview
Table 73. NanoViricides Inc. Coronavirus Infection Product
Table 74. NanoViricides Inc. Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 75. NanoViricides Inc. Recent Development
Table 76. Novavax Inc. Company Details
Table 77. Novavax Inc. Business Overview
Table 78. Novavax Inc. Coronavirus Infection Product
Table 79. Novavax Inc. Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 80. Novavax Inc. Recent Development
Table 81. Organic Vaccines Company Details
Table 82. Organic Vaccines Business Overview
Table 83. Organic Vaccines Coronavirus Infection Product
Table 84. Organic Vaccines Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 85. Organic Vaccines Recent Development
Table 86. Phelix Therapeutics LLC Company Details
Table 87. Phelix Therapeutics LLC Business Overview
Table 88. Phelix Therapeutics LLC Coronavirus Infection Product
Table 89. Phelix Therapeutics LLC Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 90. Phelix Therapeutics LLC Recent Development
Table 91. Regeneron Pharmaceuticals Inc. Company Details
Table 92. Regeneron Pharmaceuticals Inc. Business Overview
Table 93. Regeneron Pharmaceuticals Inc. Coronavirus Infection Product
Table 94. Regeneron Pharmaceuticals Inc. Revenue in Coronavirus Infection Business (2020-2025) & (US$ Million)
Table 95. Regeneron Pharmaceuticals Inc. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Coronavirus Infection Picture
Figure 2. Global Coronavirus Infection Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Coronavirus Infection Market Share by Type: 2024 VS 2031
Figure 4. FBR-001 Features
Figure 5. INO-4500 Features
Figure 6. Interferon α-n3 Features
Figure 7. Interferon β-1ａ Features
Figure 8. LCA-60 Features
Figure 9. Infect Small Molecules Features
Figure 10. MERS-CoV Vaccine Features
Figure 11. Monclonalantiboby Features
Figure 12. Global Coronavirus Infection Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Coronavirus Infection Market Share by Application: 2024 VS 2031
Figure 14. Hospital Case Studies
Figure 15. Clinic Case Studies
Figure 16. Other Case Studies
Figure 17. Coronavirus Infection Report Years Considered
Figure 18. Global Coronavirus Infection Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Coronavirus Infection Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Coronavirus Infection Market Share by Region: 2024 VS 2031
Figure 21. Global Coronavirus Infection Market Share by Players in 2024
Figure 22. Global Top Coronavirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Infection as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Coronavirus Infection Revenue in 2024
Figure 24. North America Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Coronavirus Infection Market Share by Country (2020-2031)
Figure 26. United States Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Coronavirus Infection Market Share by Country (2020-2031)
Figure 30. Germany Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Coronavirus Infection Market Share by Region (2020-2031)
Figure 38. China Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Coronavirus Infection Market Share by Country (2020-2031)
Figure 46. Mexico Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Coronavirus Infection Market Share by Country (2020-2031)
Figure 50. Turkey Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Coronavirus Infection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. AstraZeneca Plc Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 54. Hemispherx Biopharma Inc. Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 55. Humabs BioMed SA Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 56. Kineta Inc. Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 57. NanoViricides Inc. Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 58. Novavax Inc. Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 59. Organic Vaccines Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 60. Phelix Therapeutics LLC Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 61. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Coronavirus Infection Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232